SYT9: A Potential Drug Target and Biomarker (G143425)

Target Name: SYT9

NCBI ID: G143425

SYT9

SYT9: A Potential Drug Target and Biomarker

Sytensin-9 (SYT9) is a protein that is expressed in various tissues of the body, including the heart, lungs, kidneys, and intestines. It is a member of the Sytensin family, which includes four structurally similar proteins that are involved in the regulation of cell signaling pathways. The function of SYT9 is not well understood, but it is thought to play a role in the regulation of cellular processes that are important for maintaining tissue homeostasis and survival.

SYT9 has been identified as a potential drug target due to its involvement in several cellular processes that are associated with a variety of diseases, including heart failure, cancer, and neurodegenerative diseases. It is also overexpressed in several types of cancer, which suggests that targeting SYT9 may be a promising strategy for the development of new treatments for these diseases.

In addition to its potential as a drug target, SYT9 has also been identified as a potential biomarker for several types of cancer. The expression of SYT9 has been observed in a variety of cancer tissues, including breast, ovarian, and colorectal cancer. This suggests that SYT9 may be a useful biomarker for the diagnosis and evaluation of these cancers.

The discovery and characterization of SYT9 as a potential drug target and biomarker opens up new avenues for research and development of treatments for a variety of diseases. While further studies are needed to fully understand the function of SYT9 and its potential as a drug and biomarker, its identification and characterization as a potential target and biomarker are significant steps forward in the search for new treatments for a variety of diseases.

Protein Name: Synaptotagmin 9

Functions: May be involved in Ca(2+)-dependent exocytosis of secretory vesicles through Ca(2+) and phospholipid binding to the C2 domain or may serve as Ca(2+) sensors in the process of vesicular trafficking and exocytosis

The "SYT9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYT9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets